
Mitchell Levesque
Articles
-
Oct 29, 2024 |
nature.com | Rebekka Wegmann |Ximena Bonilla |Ricardo Coelho |Sandra Goetze |Francis Jacob |Jack Kuipers | +17 more
AbstractDeep single-cell multi-omic profiling offers a promising approach to understand and overcome drug resistance in relapsed or refractory (rr) acute myeloid leukemia (AML). Here, we combine single-cell ex vivo drug profiling (pharmacoscopy) with single-cell and bulk DNA, RNA, and protein analyses, alongside clinical data from 21 rrAML patients.
-
Jul 20, 2023 |
nature.com | Carmen Reitinger |Kilian Wistuba-Hamprecht |Hubert Hackl |Hemant Joshi |Phil Cheng |Mitchell Levesque | +13 more
Proteins and antibodiesHIS-tagged recombinant human Growth and Differentiation Factor-15 was produced in HEK293T cells (Invigate GmbH, Jena). The anti-human GDF-15 antibody used in this manuscript was generated in female C57BL/6J GDF-15-/–mice kindly provided by Dr. Jens Strelau (Heidelberg, Germany) and validated for binding affinity by surface plasmon resonance at NMI (Reutlingen, Germany). Specificity was tested by tissue cross-reactivity studies.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →